Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
69.02 (1y: +56%)
Market Cap 3.81 B P/E(ttm) 28.90
Enterprise Value 3.73 B P/B 3.96
SIRO- NAS (USA)
Sirona Dental Systems, Inc.
  • Currently 2/5
Business Predictability Rank: 2-Star
Back Testing Results:
Average gain of all 2-Star stocks: 6% per year.
% of Stocks that are in still loss if held for 10yrs: 16%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$69.02
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry		 vs
history
Cash to Debt 2.002
SIRO's Cash to Debt is ranked lower than
628930% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. SIRO: 2.002 )
SIRO' s 10-Year Cash to Debt Range
Min: 0.15   Max: No Debt
Current: 2
Equity to Asset 0.047
SIRO's Equity to Asset is ranked lower than
699300% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.56 vs. SIRO: 0.047 )
SIRO' s 10-Year Equity to Asset Range
Min: -0.48   Max: 0.88
Current: 0.05
-0.48
0.88
Interest Coverage 49.3
SIRO's Interest Coverage is ranked lower than
877192% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 73.90 vs. SIRO: 49.3 )
SIRO' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: 49.3
F-Score: 8
Z-Score: 6.05
M-Score: -2.77
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry		 vs
history
Operating margin (%) 19.00
SIRO's Operating margin (%) is ranked lower than
892856% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.00 vs. SIRO: 19.00 )
SIRO' s 10-Year Operating margin (%) Range
Min: -2.7   Max: 35.8
Current: 19
-2.7
35.8
Net-margin (%) 13.7
SIRO's Net-margin (%) is ranked lower than
980391% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.20 vs. SIRO: 13.7 )
SIRO' s 10-Year Net-margin (%) Range
Min: -7.7   Max: 46
Current: 13.7
-7.7
46
ROE (%) 13.5
SIRO's ROE (%) is ranked lower than
990098% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.30 vs. SIRO: 13.5 )
SIRO' s 10-Year ROE (%) Range
Min: 0.2   Max: 106.5
Current: 13.5
0.2
106.5
ROA (%) 9
SIRO's ROA (%) is ranked lower than
980391% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.30 vs. SIRO: 9 )
SIRO' s 10-Year ROA (%) Range
Min: -13   Max: 52.3
Current: 9
-13
52.3
ROC (Joel Greenblatt) (%) 86.10
SIRO's ROC (Joel Greenblatt) (%) is ranked lower than
900900% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.40 vs. SIRO: 86.10 )
SIRO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -22.1   Max: 265.1
Current: 86.1
-22.1
265.1
Revenue Growth (%) 7.6
SIRO's Revenue Growth (%) is ranked lower than
1176469% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.60 vs. SIRO: 7.6 )
SIRO' s 10-Year Revenue Growth (%) Range
Min: -1.7   Max: 55.8
Current: 7.6
-1.7
55.8
EBITDA Growth (%) 10
SIRO's EBITDA Growth (%) is ranked lower than
1587300% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.70 vs. SIRO: 10 )
SIRO' s 10-Year EBITDA Growth (%) Range
Min: -0.2   Max: 57
Current: 10
-0.2
57
EPS Growth (%) 25.2
SIRO's EPS Growth (%) is ranked lower than
1923075% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.30 vs. SIRO: 25.2 )
SIRO' s 10-Year EPS Growth (%) Range
Min: -63   Max: 163.2
Current: 25.2
-63
163.2
ยป SIRO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

SIRO Guru Trades in Q2 2012

Joel Greenblatt 11,092 sh (New)
Paul Tudor Jones 6,400 sh (New)
Steven Cohen 60,955 sh (New)
Ruane Cunniff 2,922,154 sh (+15.55%)
Lee Ainslie Sold Out
Manning & Napier Advisors, Inc 224,050 sh (-0.54%)
Columbia Wanger 1,227,300 sh (-2.93%)
RS Investment Management 324,569 sh (-78.97%)
» More
Q3 2012

SIRO Guru Trades in Q3 2012

Ron Baron 16,800 sh (New)
Paul Tudor Jones 152,200 sh (+2278.13%)
Columbia Wanger 1,693,805 sh (+38.01%)
Manning & Napier Advisors, Inc 225,850 sh (+0.8%)
RS Investment Management Sold Out
Ruane Cunniff 2,918,603 sh (-0.12%)
Joel Greenblatt 8,876 sh (-19.98%)
Steven Cohen 13,193 sh (-78.36%)
» More
Q4 2012

SIRO Guru Trades in Q4 2012

Jim Simons 105,000 sh (New)
Manning & Napier Advisors, Inc 229,750 sh (+1.73%)
Columbia Wanger 1,701,323 sh (+0.44%)
Ruane Cunniff 2,922,875 sh (+0.15%)
Ron Baron 16,800 sh (unchged)
Joel Greenblatt 7,043 sh (-20.65%)
Steven Cohen 7,767 sh (-41.13%)
Paul Tudor Jones 3,400 sh (-97.77%)
» More
Q1 2013

SIRO Guru Trades in Q1 2013

Paul Tudor Jones 5,400 sh (+58.82%)
Steven Cohen 10,563 sh (+36%)
Manning & Napier Advisors, Inc 233,650 sh (+1.7%)
Ruane Cunniff 2,933,394 sh (+0.36%)
Ron Baron 16,800 sh (unchged)
Columbia Wanger 1,677,266 sh (-1.41%)
Joel Greenblatt 6,703 sh (-4.83%)
Jim Simons 33,100 sh (-68.48%)
» More
» Details

Insider Trades

Latest Guru Trades with SIRO

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2012-12-31 Reduce -20.65%0.01%$55.02 - $63.08 $ 69.0216%7043
Ron Baron 2012-09-30 New Buy0.01%$41.78 - $57.16 $ 69.0240%16800
Lee Ainslie 2012-06-30 Sold Out 0.79%$41.08 - $51.93 $ 69.0247%0
Ruane Cunniff 2012-06-30 Add 15.55%0.15%$41.08 - $51.93 $ 69.0247%2922154
Joel Greenblatt 2012-06-30 New Buy0.04%$41.08 - $51.93 $ 69.0247%11092
Lee Ainslie 2012-03-31 Reduce -40.97%0.45%$43.15 - $52.38 $ 69.0253%1071713
Lee Ainslie 2011-12-31 New Buy1.1%$39.73 - $49.43 $ 69.0257%1815539
Ruane Cunniff 2011-12-31 Add 3995.82%0.94%$39.73 - $49.43 $ 69.0257%2523229
Ruane Cunniff 2011-09-30 New Buy0.03%$39.55 - $56 $ 69.0245%61605
Joel Greenblatt 2011-06-30 Sold Out 0.08%$50.41 - $57.07 $ 69.0230%0
Joel Greenblatt 2011-03-31 New Buy0.08%$40.95 - $52.07 $ 69.0246%5215
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 28.90
SIRO's P/E(ttm) is ranked lower than
934579% of the 107 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.90 vs. SIRO: 28.90 )
SIRO' s 10-Year P/E(ttm) Range
Min: 3.67   Max: 782.2
Current: 28.9
3.67
782.2
P/B 3.96
SIRO's P/B is ranked lower than
657894% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. SIRO: 3.96 )
SIRO' s 10-Year P/B Range
Min: 0.84   Max: 50
Current: 3.96
0.84
50
P/S 3.78
SIRO's P/S is ranked lower than
628930% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. SIRO: 3.78 )
SIRO' s 10-Year P/S Range
Min: 0.14   Max: 12.73
Current: 3.78
0.14
12.73
PFCF 22.34
SIRO's PFCF is ranked lower than
1063829% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.70 vs. SIRO: 22.34 )
SIRO' s 10-Year PFCF Range
Min: 1.72   Max: 86.91
Current: 22.34
1.72
86.91
EV-to-EBIT 18.87
SIRO's EV-to-EBIT is ranked lower than
704225% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.73 vs. SIRO: 18.87 )
SIRO' s 10-Year EV-to-EBIT Range
Min: 3.4   Max: 92.6
Current: 18.87
3.4
92.6
PEG 2.45
SIRO's PEG is ranked lower than
1694914% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. SIRO: 2.45 )
SIRO' s 10-Year PEG Range
Min: 0.33   Max: 15.3
Current: 2.45
0.33
15.3
Shiller P/E 40.08
SIRO's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: vs. SIRO: 40.08 )
SIRO' s 10-Year Shiller P/E Range
Min: 11.64   Max: 86.5
Current: 40.08
11.64
86.5

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 29
SIRO's Price/Net Current Asset Value is ranked lower than
684931% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.00 vs. SIRO: 29 )
SIRO' s 10-Year Price/Net Current Asset Value Range
Min: 5.3   Max: 74.5
Current: 29
5.3
74.5
Price/Tangible Book 56.2
SIRO's Price/Tangible Book is ranked lower than
704225% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.60 vs. SIRO: 56.2 )
SIRO' s 10-Year Price/Tangible Book Range
Min: 4.5   Max: 46.3
Current: 56.2
4.5
46.3
Price/DCF (Projected) 1.9
SIRO's Price/DCF (Projected) is ranked lower than
1538460% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. SIRO: 1.9 )
SIRO' s 10-Year Price/DCF (Projected) Range
Min: 1.1   Max: 4.7
Current: 1.9
1.1
4.7
Price/Median PS Value 1.5
SIRO's Price/Median PS Value is ranked lower than
649350% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. SIRO: 1.5 )
SIRO' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 4.7
Current: 1.5
0.2
4.7
Price/Peter Lynch Fair Value 2.4
SIRO's Price/Peter Lynch Fair Value is ranked lower than
3124997% of the 32 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. SIRO: 2.4 )
SIRO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.3   Max: 3.7
Current: 2.4
1.3
3.7
Price/Graham Number 8.5
SIRO's Price/Graham Number is ranked lower than
1041666% of the 96 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. SIRO: 8.5 )
SIRO' s 10-Year Price/Graham Number Range
Min: 1   Max: 7
Current: 8.5
1
7
Earnings Yield (Greenblatt) 5.30
SIRO's Earnings Yield (Greenblatt) is ranked lower than
799999% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. SIRO: 5.30 )
SIRO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 29.7
Current: 5.3
1.1
29.7
Forward Rate of Return (Yacktman) 13.94
SIRO's Forward Rate of Return (Yacktman) is ranked lower than
1960782% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.37 vs. SIRO: 13.94 )
SIRO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.6   Max: 55.5
Current: 13.94
1.6
55.5

Business Description

Sirona Dental Systems, Inc. was founded in 1992 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, technologically-advanced dental equipment, and is focused on developing, manufacturing and marketing innovative solutions for dentists around the world. The Company provides a range of technologically advanced products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The global dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the worldwide market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise a range of products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 350 distributors. The Company's registered trademarks include, 'Sirona,' 'CEREC,' 'Orthophos,' 'Heliodent,' 'inLab,' 'CDR,' and 'Schick'. It competes with different companies which include large international companies as well as smaller companies that comp
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO
Traded in other countries:RXT.Germany
ยป More Articles for SIRO

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CEO Buys Highlight: KMI, VGR, SIRO, PNK, MASI Nov 27 2011 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Nov 18 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Feb 23 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Dec 17 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Dec 04 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Jul 31 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) May 06 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Feb 05 2009 

More From Our Partners
Will Patterson Miss Earnings this Quarter? - Analyst Blog May 22 2013 - ZACKS

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial